NeuroLeap raises funds for expansion
The company uses brain computer interface (BCI) technology to offer bespoke neural assessment and therapy for mental health conditions.
“People suffer from disorders like clinical depression for decades, but our solution has been proven to help patients over a period of a few months,” said Kumaar Bagrodia, founder of NeuroLeap. “We will look to make this solution more accessible in the future, but even today we can deliver far better results than other methods for treating mental health conditions.”
With clinics in Mumbai and Delhi, Neuro-Leap will expand its presence in the coming year to include a few more metro cities.